Novo Nordisk requests HSE to cover Wegovy on medical card 

Danish firm Novo Nordisk has applied to Ireland's health service to add Wegovy to the State’s medical card and community drug schemes. File picture

The makers of obesity drug Wegovy have submitted a full request to the HSE for it to be covered on medical cards and other drug payment schemes.

So far only one obesity treatment — Saxenda — is covered for patients struggling with this condition. Others are also under assessment.